TR201901325T4 - Canlı olmayan bifidobakteriyuma ve sindirilebilir olmayan oligosakkarite sahip besin. - Google Patents

Canlı olmayan bifidobakteriyuma ve sindirilebilir olmayan oligosakkarite sahip besin. Download PDF

Info

Publication number
TR201901325T4
TR201901325T4 TR2019/01325T TR201901325T TR201901325T4 TR 201901325 T4 TR201901325 T4 TR 201901325T4 TR 2019/01325 T TR2019/01325 T TR 2019/01325T TR 201901325 T TR201901325 T TR 201901325T TR 201901325 T4 TR201901325 T4 TR 201901325T4
Authority
TR
Turkey
Prior art keywords
food
digestible oligosaccharide
bifidobacterium
living
living bifidobacterium
Prior art date
Application number
TR2019/01325T
Other languages
English (en)
Turkish (tr)
Inventor
Hougee Sander
Johannes Maria Vriesema Adrianus
Garssen Johan
Knol Jan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of TR201901325T4 publication Critical patent/TR201901325T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR2019/01325T 2007-06-15 2008-06-13 Canlı olmayan bifidobakteriyuma ve sindirilebilir olmayan oligosakkarite sahip besin. TR201901325T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2007/050290 WO2008153377A1 (en) 2007-06-15 2007-06-15 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide

Publications (1)

Publication Number Publication Date
TR201901325T4 true TR201901325T4 (tr) 2019-02-21

Family

ID=39363590

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/01325T TR201901325T4 (tr) 2007-06-15 2008-06-13 Canlı olmayan bifidobakteriyuma ve sindirilebilir olmayan oligosakkarite sahip besin.

Country Status (18)

Country Link
US (2) US9456629B2 (pt)
EP (2) EP2162020B1 (pt)
CN (2) CN101801220A (pt)
AR (1) AR067020A1 (pt)
AU (1) AU2008262670B2 (pt)
BR (1) BRPI0813391B1 (pt)
CA (1) CA2691563C (pt)
CY (1) CY1121400T1 (pt)
ES (1) ES2706606T3 (pt)
HR (1) HRP20190180T1 (pt)
HU (1) HUE042392T2 (pt)
MY (1) MY162245A (pt)
NZ (1) NZ582264A (pt)
PL (1) PL2162020T3 (pt)
RU (1) RU2475051C2 (pt)
TR (1) TR201901325T4 (pt)
UA (1) UA100985C2 (pt)
WO (2) WO2008153377A1 (pt)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
BRPI0821165B8 (pt) * 2007-12-07 2021-05-25 Nutricia Nv uso de uma composição
WO2009151331A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Immune system stimulating nutrition
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
CN102325458B (zh) * 2008-12-19 2014-02-26 雀巢产品技术援助有限公司 预防及治疗轮状病毒腹泻
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2405918B2 (en) † 2009-03-13 2020-09-02 The Regents of The University of California Prebiotic oligosaccharides
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
ES2382263T3 (es) * 2009-05-11 2012-06-06 Nestec S.A. Prevención y tratamiento de la diarrea alérgica
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
ITMI20091034A1 (it) * 2009-06-11 2010-12-12 Parmalat Spa Specie probiotica di bifidobacterium breve
BE1019755A3 (fr) 2009-08-18 2012-12-04 Cosucra Groupe Warcoing S A Compositions contenant des melanges de fibres fermentescibles.
MY163002A (en) 2009-08-18 2017-07-31 Nestec Sa A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
EP2308498A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011149336A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2575509A1 (en) * 2010-06-04 2013-04-10 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455094A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
RU2600877C2 (ru) * 2010-12-06 2016-10-27 Н.В. Нютрисиа Ферментированное детское питание
MX388089B (es) 2010-12-31 2025-03-19 Abbott Lab Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
EP2658400A2 (en) 2010-12-31 2013-11-06 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
EP3338784B1 (en) 2010-12-31 2020-07-22 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
BR112013016929A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
NZ611807A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
BR112013019522A2 (pt) 2011-02-04 2019-09-24 Univ California dissialil lacto-n-tetraose (dslnt) ou as variantes, os isômeros, os análogos e os derivados da mesma para prevenir ou inibir doença do intestino
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
PT2734049T (pt) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc Composições e métodos probióticos
WO2012177118A1 (en) 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
BR112014000322A2 (pt) * 2011-07-12 2017-01-10 Nestec Sa "probióticos, e seus usos"
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US9662358B2 (en) * 2011-10-18 2017-05-30 Nestec S.A. Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease
PL2768313T3 (pl) * 2011-10-18 2016-02-29 Nestec Sa Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie
CN104039175A (zh) * 2011-10-24 2014-09-10 N·V·努特里奇亚 使用非消化性低聚糖的变态反应疗法
WO2013187755A1 (en) * 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
EP3936134B1 (en) * 2012-11-02 2026-03-04 N.V. Nutricia Synbiotics combination for brain improvement
EP2925162A1 (en) * 2012-11-29 2015-10-07 Nestec S.A. Synbiotic composition and use thereof
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
BR112016009357B1 (pt) * 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
AU2014359705A1 (en) * 2013-11-25 2016-05-05 Nestec S.A. Heat-treated formulation of Bifidobacterium lactis NCC 2818 reduces allergic manifestations
WO2016053085A1 (en) 2014-09-30 2016-04-07 N.V. Nutricia Composition comprising a uridine source and butyrate producing fibres for preventing gastrointestinal disorders
CN107249611A (zh) * 2014-10-24 2017-10-13 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
US10609475B2 (en) 2014-12-05 2020-03-31 Stages Llc Active noise control and customized audio system
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
PT3264922T (pt) 2015-03-05 2025-01-07 Nestle Sa Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2017043962A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Method for stimulating microbiota health after non-natural birth
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108697141A (zh) * 2015-12-29 2018-10-23 N·V·努特里奇亚 含有不可消化寡糖和非复制型产乳酸细菌的营养配方物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
CN116196340A (zh) * 2016-05-31 2023-06-02 森永乳业株式会社 脑功能改善剂
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
EP4159224A1 (en) * 2017-06-30 2023-04-05 N.V. Nutricia Synbiotic composition for preventing chronic inflammation
CN110831609A (zh) * 2017-06-30 2020-02-21 N·V·努特里奇亚 用于预防代谢紊乱的合生素组合物
ES3039971T3 (en) 2017-12-08 2025-10-28 Chr Hansen Hmo Gmbh Spray-dried 3-fucosyllactose
PL3494805T3 (pl) 2017-12-08 2025-10-06 Chr. Hansen HMO GmbH Suszone rozpyłowo tetrasacharydy
US11857579B2 (en) * 2018-03-23 2024-01-02 Morinaga Milk Industry Co., Ltd. Composition for promoting the secretion of FGF21
TW202023590A (zh) * 2018-08-17 2020-07-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
US20240307338A1 (en) * 2021-01-27 2024-09-19 Sichuan Jiuzhang Biological Science And Technology Co., Ltd. Use of pharmaceutical composition containing chlorogenic acid in preparation of medicament for treating pathologic jaundice
CN114767720A (zh) * 2022-05-12 2022-07-22 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备药物中的应用
CN114949006A (zh) * 2022-06-10 2022-08-30 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备缓解卵清蛋白诱导的食物过敏药物中的应用
EP4385340A1 (de) * 2022-12-15 2024-06-19 DMK Deutsches Milchkontor GmbH Prebiotische zubereitungen
EP4574160A1 (en) * 2023-12-20 2025-06-25 Hipp & Co Composition comprising bifidobacterium breve strain for use in the prevention of skin allergies

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6077558A (en) * 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
WO2001013956A2 (en) 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030157067A1 (en) * 2002-02-19 2003-08-21 Bartels Jennifer F. Formulation and method for preventing antibiotics-induced diaper rash
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
JP4740866B2 (ja) * 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
US20090257993A1 (en) * 2003-12-17 2009-10-15 M Rabet Laura Lactic Acid Producing Bacteria and Lung Function
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
DK1629850T4 (da) * 2004-08-24 2013-07-01 Nutricia Nv Næringssammensætning indeholdende ufordøjelige oligosaccharider
PL2805625T5 (pl) * 2005-02-28 2023-03-13 N.V. Nutricia Kompozycja odżywcza z prebiotykami i probiotykami
AU2006233918B2 (en) * 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
CN101166428B (zh) 2005-04-27 2015-03-04 努特里希亚公司 含脂类和不易消化的糖的营养品
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide

Also Published As

Publication number Publication date
ES2706606T3 (es) 2019-03-29
PL2162020T3 (pl) 2019-04-30
CN101801220A (zh) 2010-08-11
EP2162020A2 (en) 2010-03-17
HRP20190180T1 (hr) 2019-03-22
WO2008153391A3 (en) 2009-02-05
AU2008262670A1 (en) 2008-12-18
WO2008153377A1 (en) 2008-12-18
AR067020A1 (es) 2009-09-30
US9883692B2 (en) 2018-02-06
US9456629B2 (en) 2016-10-04
HUE042392T2 (hu) 2019-06-28
CY1121400T1 (el) 2020-05-29
US20170049143A1 (en) 2017-02-23
BRPI0813391B1 (pt) 2018-12-11
CA2691563A1 (en) 2008-12-18
CN105639631A (zh) 2016-06-08
UA100985C2 (ru) 2013-02-25
EP2162020B1 (en) 2018-10-31
RU2010101056A (ru) 2011-07-20
CA2691563C (en) 2016-08-02
WO2008153391A2 (en) 2008-12-18
MY162245A (en) 2017-05-31
US20100278781A1 (en) 2010-11-04
AU2008262670B2 (en) 2014-02-13
NZ582264A (en) 2012-03-30
RU2475051C2 (ru) 2013-02-20
BRPI0813391A2 (pt) 2014-12-30
EP3491938A1 (en) 2019-06-05

Similar Documents

Publication Publication Date Title
MY162245A (en) Nutrition with non-viable bifidabacterium and non-digestible
TR201902529T4 (tr) Bağışıklığı etkileyen besin bileşimi.
BR112015009579A2 (pt) uso de glutamina, bifidobacterium breve e pelo menos um oligossacarídeo não digerível, kit de partes, composição nutricional, e método não terapêutico para melhora do desempenho cognitivo, desenvolvimento cognitivo, desempenho comportamental, desenvolvimento comportamental e/ou interação social em um bebê ou criança
ECSP12011820A (es) Estabilización probiótica
MX340938B (es) Regimenes dieteticos utiles para imitar la restriccion calorica.
FR2956962B1 (fr) Nouvel oreiller ergonomique et ses utilisations en literie
Hassanzadeh et al. Semtab 2019: Semantic web challenge on tabular data to knowledge graph matching data sets
TR201819189T4 (tr) Noktüri İle Bozulmayan İlk Uyku Periyodunun Arttırılması İçin Ağızda Dağılan Desmopressin
GB0905800D0 (en) Hardware reset
Yokoyama et al. A Discussion Model for System Design Novices
Ogata et al. Methods for Generalizing the Propp-Based Story Generation Mechanism
TR200902338U (tr) Üç ayaklı dengeli tabure.
SG144779A1 (en) Zero-forcing mimo-ofdm detection and detectors
Dynes et al. Practical treatment of quantum bugs
TR200500475U (tr) Emzirme yastığu/minderi
Akihisa et al. Error Detection with Soft Typing for Dynamically Typed Languages
Bakken Martin named associate professor emerita in the School of Education
Hamasuna et al. Fuzzy c-Means Clustering with Mutual Relation Constraints
関口昌由 A theorem on linear subproblem of newtonian N bodies
CN301037283S (zh) 办公椅座靠垫(车缝6330)
CN300895667S (zh) 电脑台(ct-2411)
TR201102371U (tr) Tuvalet kilidi.
TR200804230U (tr) Doğalgaz bacasında yenilik
CN301090337S (zh) 电源柜(sg500ktl)
CN301139389S (zh) 电源柜(sg250k3)